Tango Therapeutics to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
June 05 2024 - 7:00AM
Business Wire
Tango Therapeutics, Inc. (NASDAQ: TNGX), a clinical-stage
biotechnology company committed to discovering and delivering the
next generation of precision cancer medicines, today announced that
Barbara Weber, M.D., President and Chief Executive Officer of Tango
Therapeutics, is scheduled to present at the Goldman Sachs 45th
Annual Global Healthcare Conference on Tuesday, June 11, 2024 at
2:40 PM ET.
A live webcast of the presentation will be available under the
"Events & Presentations" tab on the “Investors” page on the
Company's website on the day of the event. A replay of the webcast
will be archived on the Company's website for 90 days following the
presentation.
About Tango Therapeutics
Tango Therapeutics is a clinical-stage biotechnology company
dedicated to discovering novel drug targets and delivering the next
generation of precision medicine for the treatment of cancer. Using
an approach that starts and ends with patients, Tango leverages the
genetic principle of synthetic lethality to discover and develop
therapies that take aim at critical targets in cancer. This
includes expanding the universe of precision oncology targets into
novel areas such as tumor suppressor gene loss and their
contribution to the ability of cancer cells to evade immune cell
killing. For more information, please visit www.tangotx.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240605891914/en/
Investor Contact: Sam Martin/Andrew Vulis Argot Partners
tango@argotpartners.com
Media Contact: Amanda Galgay SVP, Corporate
Communications, Tango Therapeutics media@tangotx.com
Tango Therapeutics (NASDAQ:TNGX)
Historical Stock Chart
From Jul 2024 to Aug 2024
Tango Therapeutics (NASDAQ:TNGX)
Historical Stock Chart
From Aug 2023 to Aug 2024